Hemophilia in Dogs: Inherited Bleeding Disorder Diagnosis Guide

Last updated: May 16, 2026

What Hemophilia Actually Is

Hemophilia in dogs is a group of inherited bleeding disorders caused by deficiency of a specific clotting factor in the coagulation cascade. The two clinically important canine forms are Hemophilia A (factor VIII deficiency) and Hemophilia B (factor IX deficiency, also called Christmas disease). Both are X-linked recessive disorders, which means the defective gene sits on the X chromosome — males who inherit the gene have only one X chromosome and are therefore affected, while females need two copies of the defective gene to be affected and most often are asymptomatic carriers. The result is a dramatic male-skewed disease distribution, with carrier dams transmitting the condition to roughly half of their male offspring.

Affected dogs cannot form stable fibrin clots normally. Small daily injuries that heal silently in a normal dog may produce dramatic bleeding episodes in a hemophiliac dog — most characteristically deep tissue bleeds (muscle hematomas, joint hemarthroses) and delayed post-surgical or post-trauma bleeding. The severity of clinical disease depends on how much residual factor activity remains; severely deficient dogs (less than 1% factor activity) bleed spontaneously, while mildly deficient dogs (5 to 25% activity) may go years before a surgical or traumatic event reveals the diagnosis.

How Hemophilia Differs From Other Bleeding Disorders

Multiple bleeding disorders exist in dogs, and the workup is partly distinguishing them. The classic hemophilia bleeding pattern is deep tissue bleeding — muscle hematomas, joint hemarthroses, body cavity bleeds — rather than the petechial-and-mucosal bleeding pattern of platelet disorders. The clinical comparisons that come up in practice include:

• Von Willebrand disease — the most common inherited bleeding disorder in dogs, autosomal (males and females equally affected), produces mucosal-and-cutaneous bleeding rather than deep tissue bleeds. Doberman Pinschers are the breed flagship, but VWD is reported across many breeds.
• ITP in dogs — acquired immune attack on platelets; produces petechiae, bruising, and mucosal bleeding rather than deep tissue bleeds.
• DIC in pets — acquired complication of severe critical illness with mixed bleeding pattern.
• Anticoagulant rodenticide ingestion — acquired vitamin K antagonism produces deep tissue bleeds and prolonged coagulation times, mimicking hemophilia in presentation but with an obvious history; vitamin K1 is the antidote.
• Liver failure — acquired deficiency of multiple liver-produced clotting factors, distinguishable by liver enzymes and clinical context.

The key differentiator for inherited hemophilia is a young intact male with deep tissue bleeding episodes and a family history of similar problems in male relatives.

How Hemophilia Looks at Home

Severity dictates presentation. Severely deficient puppies may show signs from a young age:

• Prolonged bleeding from the umbilical stump after birth
• Bleeding gums during teething
• Spontaneous nosebleeds
• Visible bruising or hematomas after minor bumps
• Reluctance to bear weight on a leg with no obvious cause (intramuscular or joint hematoma)
• Swelling and pain over a deep muscle group
• Pale gums, weakness, or collapse with internal bleeding into a body cavity
• Bleeding into the urine (hematuria) or stool

Mildly deficient dogs often present later in life when a routine spay, neuter, dental cleaning, or other surgery produces unexpected and prolonged post-operative bleeding. The post-surgical hematoma at a routine procedure that “should have been straightforward” is a classic presentation. Some dogs are diagnosed only after a traumatic injury produces an out-of-proportion bleeding episode.

Which Breeds Are Predisposed

Hemophilia A (factor VIII deficiency) has been reported across many breeds and in mixed-breed dogs. Breeds repeatedly cited in the published veterinary literature include German Shepherd Dogs, Doberman Pinschers (separate from VWD predisposition), Golden Retrievers, Labrador Retrievers, English Setters, Boxers, Schnauzers, Beagles, Cocker Spaniels, and Poodles. Hemophilia B (factor IX deficiency) is less common and has been reported in similar breed clusters. Specific lines within breeds carry the disease, which is why breeding decisions in known-affected lines benefit from theriogenology consultation. The disease is genetic and not preventable in an affected dog; it is preventable at the breeding-decision level by genetic screening of carriers.

The Diagnostic Workup

The workup begins when bleeding signs or post-operative complications suggest a coagulation problem and progresses to specific factor assays:

• CBC with platelet count and smear — typically normal in hemophilia (platelets are not the problem); rules out thrombocytopenia.
• Buccal mucosal bleeding time (BMBT) — typically normal in hemophilia (platelet-dependent screen); often prolonged in VWD.
• Coagulation panel — PT and aPTT — aPTT is prolonged in hemophilia A and B (intrinsic pathway); PT is normal. The pattern of normal PT and prolonged aPTT in a young intact male with deep tissue bleeding is highly suggestive.
• Specific factor VIII and factor IX assays — definitive diagnosis. Quantifies residual activity and distinguishes Hemophilia A from B.
• Von Willebrand factor antigen and activity — run in parallel to rule out concurrent or alternative VWD.
• Genetic testing — available for some specific factor IX mutations and a subset of factor VIII mutations; useful in known-affected breeding lines for carrier identification.

Diagnosis is made by the specific factor assay. Carrier-female testing requires either factor activity measurement (carriers typically have intermediate activity around 50% of normal, with overlap into normal range) or specific mutation-based genetic testing where available.

Acute Treatment of Bleeding Episodes

Active bleeding episodes are managed with replacement of the missing clotting factor and supportive care:

• Fresh whole blood — provides red cells plus all coagulation factors plus platelets; most useful when significant blood loss has occurred.
• Fresh frozen plasma (FFP) — provides all coagulation factors without red cells; cornerstone of hemophilia transfusion therapy when red-cell loss is not the primary issue.
• Cryoprecipitate — concentrated source of factor VIII, fibrinogen, and von Willebrand factor; useful for Hemophilia A specifically when available.
• Specific factor concentrates — human or recombinant factor VIII and factor IX products are sometimes used at referral hospitals in select cases; cost and availability are limitations.
• Local hemostasis — pressure, ice, and conservative immobilization for limb bleeds; topical hemostatic agents at incision sites.
• Pain control — gabapentin and opioids for joint and muscle hematomas; NSAIDs are avoided because they impair platelet function.
• IV fluid therapy and supportive care — for blood-loss anemia and shock.

Lifetime Planning for Affected Dogs

Hemophilia is a lifetime condition. Practical planning includes:

• Medical alert documentation — every veterinary record, every boarding record, and every household contact should know the dog has hemophilia. A medical-alert tag on the collar is reasonable.
• Pre-procedure planning — any planned surgery, dental cleaning, biopsy, or invasive procedure benefits from advance coordination with the surgical team and a transfusion plan in place; for some procedures, prophylactic factor replacement at the time of surgery is needed.
• Activity modifications — affected dogs typically still enjoy walks and gentle play, but rough play with other dogs, jumping from heights, and contact sports are reasonable to limit. Crate or fenced-yard supervision rather than free-roaming is sensible.
• NSAID avoidance — NSAIDs impair platelet function and worsen bleeding; pain control plans should be NSAID-free.
• Avoid intramuscular injections when possible — IM injections can produce muscle hematomas. Subcutaneous and IV routes are preferred.
• Tick and parasite prevention — tick-borne disease can produce additional bleeding tendencies in an already-fragile dog. Strict prevention matters more for these dogs.
• Owner education — recognizing early signs of bleeding (lethargy, pale gums, swelling over a muscle, reluctance to use a limb) and knowing the emergency-vet plan in advance shortens the time to treatment when episodes happen.

Breeding and Genetic Counseling

Hemophilia is fully preventable at the population level by removing affected males and carrier females from breeding programs. Where genetic testing is available for the specific mutation in a line, carriers can be identified before breeding decisions. Where genetic testing is not available, factor activity measurement in candidate breeding females can identify likely carriers, with the caveat that activity-based testing has overlap between carriers and non-carriers. Theriogenology (American College of Theriogenologists, ACT) consultation is the right specialist for breeding-program decisions in known-affected lines.

Long-Term Outlook

Prognosis varies dramatically with severity. Severely deficient dogs face a more guarded long-term outlook because spontaneous bleeding episodes are unpredictable; chronic joint disease can develop from repeated hemarthroses, mirroring the joint changes seen in human hemophiliacs. Mildly to moderately deficient dogs can live close-to-normal lifespans with informed lifetime management and transfusion support around procedures and traumatic events. Owner vigilance, household and lifestyle planning, and a relationship with an emergency vet who knows the dog produce the best outcomes. Insurance and finance planning matters because each transfusion-requiring episode is a meaningful cost.

Cost Realism and Insurance Timing

Diagnosis (factor assays at a specialty laboratory) is moderately expensive. Each transfusion event runs into the hundreds-to-thousands-of-dollars range depending on the volume of blood products needed and the length of hospitalization. A single major surgery in an affected dog can produce a substantial bill from prophylactic transfusion plus monitoring. Pet insurance is most useful when purchased before any bleeding-disorder diagnosis appears on the medical record; see our pet insurance decision for dogs overview. Some inherited conditions have insurance exclusions even when policies are purchased before diagnosis, so reading policy fine print matters. The emergency vet cost realism guide helps frame transfusion-event costs.

Living With and Adopting a Hemophiliac Dog

Hemophiliac dogs in informed households live full and meaningful lives. The household commitment is awareness, NSAID-free pain management, careful activity choices, prompt response to bleeding signs, and a coordinated care plan with the primary vet and emergency hospital. Adopting a dog with diagnosed hemophilia is reasonable for households able to absorb the medical and financial planning; the rescue should provide complete medical records, factor assay results, surgical history, and any prior transfusion events, and the future vet should review everything before commitment. Many of these dogs are deeply bonded with their caregivers and adopt beautifully where the household is prepared.

When to See Your Vet — and When to Go Straight to the ER

Schedule a primary-vet visit promptly for any unexpected bleeding episode in a known hemophiliac dog, any new lameness or visible swelling, any change in gum color, or any concern about post-procedural bleeding. Go directly to the emergency vet for active bleeding that does not stop with pressure, suspected internal bleeding (collapse, pale gums, distended abdomen), or rapid clinical deterioration. ACVIM-Internal Medicine specialists manage complex hemophilia cases and coordinate transfusion plans. ACT theriogenology specialists are the resource for breeding-program decisions in affected lines. The veterinary specialist cost breakdown helps you plan financially.

Frequently Asked Questions

Can female dogs have hemophilia?

Female dogs with hemophilia exist but are uncommon — they would need to inherit the defective gene from both parents (an affected sire and a carrier dam), which requires deliberate or accidental breeding of carriers. The vast majority of affected dogs in clinical practice are males; females are most often asymptomatic carriers.

Can hemophilia in dogs be cured?

No. Hemophilia is an inherited factor deficiency without a curative therapy in current veterinary medicine. Lifetime management with transfusion support around bleeding events and informed lifestyle planning is the realistic plan. Gene therapy research exists in human medicine but is not currently available for veterinary patients.

What about hemophilia in cats?

Hemophilia A and B are reported in cats but are uncommon. The same X-linked inheritance pattern applies. Affected cats are managed with transfusion support and lifestyle planning similar to dogs; the cat-specific picture is less well-characterized in the literature than the dog-specific picture.

Can my hemophiliac dog still be neutered?

Yes, but advance planning is essential. The procedure should be done at a hospital with transfusion capability, with a coordinated transfusion plan in place. Many vets prefer to schedule a CBC and coagulation panel preoperatively even in dogs without prior bleeding episodes, given the post-surgical bleeding risk. Talk to your vet well in advance.

Should I avoid all NSAIDs in a hemophiliac dog?

Yes. NSAIDs impair platelet function and worsen bleeding tendency. Pain control plans for affected dogs are NSAID-free, using gabapentin, opioids in acute settings, and other modalities under vet guidance. Always confirm any pain medication with your primary vet before giving it to a hemophiliac dog.